1. Home
  2. UPB vs IMKTA Comparison

UPB vs IMKTA Comparison

Compare UPB & IMKTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPB
  • IMKTA
  • Stock Information
  • Founded
  • UPB 2021
  • IMKTA 1963
  • Country
  • UPB United States
  • IMKTA United States
  • Employees
  • UPB N/A
  • IMKTA N/A
  • Industry
  • UPB
  • IMKTA Food Chains
  • Sector
  • UPB
  • IMKTA Consumer Staples
  • Exchange
  • UPB NYSE
  • IMKTA Nasdaq
  • Market Cap
  • UPB 1.3B
  • IMKTA 1.2B
  • IPO Year
  • UPB 2024
  • IMKTA N/A
  • Fundamental
  • Price
  • UPB $17.80
  • IMKTA $70.33
  • Analyst Decision
  • UPB Strong Buy
  • IMKTA
  • Analyst Count
  • UPB 4
  • IMKTA 0
  • Target Price
  • UPB $56.50
  • IMKTA N/A
  • AVG Volume (30 Days)
  • UPB 252.2K
  • IMKTA 130.0K
  • Earning Date
  • UPB 11-07-2024
  • IMKTA 12-02-2024
  • Dividend Yield
  • UPB N/A
  • IMKTA 0.94%
  • EPS Growth
  • UPB N/A
  • IMKTA N/A
  • EPS
  • UPB N/A
  • IMKTA 8.40
  • Revenue
  • UPB $2,207,000.00
  • IMKTA $5,827,075,484.00
  • Revenue This Year
  • UPB N/A
  • IMKTA N/A
  • Revenue Next Year
  • UPB N/A
  • IMKTA N/A
  • P/E Ratio
  • UPB N/A
  • IMKTA $8.27
  • Revenue Growth
  • UPB 82.10
  • IMKTA 1.17
  • 52 Week Low
  • UPB $17.09
  • IMKTA $59.73
  • 52 Week High
  • UPB $29.46
  • IMKTA $89.59
  • Technical
  • Relative Strength Index (RSI)
  • UPB N/A
  • IMKTA 58.35
  • Support Level
  • UPB N/A
  • IMKTA $68.34
  • Resistance Level
  • UPB N/A
  • IMKTA $72.93
  • Average True Range (ATR)
  • UPB 0.00
  • IMKTA 1.79
  • MACD
  • UPB 0.00
  • IMKTA 0.10
  • Stochastic Oscillator
  • UPB 0.00
  • IMKTA 63.27

About UPB UPSTREAM BIO INC

Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune mediated diseases.

About IMKTA Ingles Markets Incorporated

Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.

Share on Social Networks: